Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Top Cited Papers
- 14 February 2020
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 94 (5)
- https://doi.org/10.1128/jvi.02015-19
Abstract
Antibody-dependent enhancement (ADE) of viral entry has been a major concern for epidemiology, vaccine development and antibody-based drug therapy. However, the molecular mechanism behind ADE is still elusive. Coronavirus spike protein mediates viral entry into cells by first binding to a receptor on host cell surface and then fusing viral and host membranes. Here we investigated how a neutralizing monoclonal antibody (mAb), which targets the receptor-binding domain (RBD) of MERS coronavirus spike, mediates viral entry using pseudovirus entry and biochemical assays. Our results showed that mAb binds to the virus-surface spike, allowing it to undergo conformational changes and become prone to proteolytic activation. Meanwhile, mAb binds to cell-surface IgG Fc receptor, guiding viral entry through canonical viral-receptor-dependent pathways. Our data suggest that the antibody/Fc-receptor complex functionally mimics viral receptor in mediating viral entry. Moreover, we characterized mAb dosages in viral-receptor-dependent, antibody-dependent, and both-receptors-dependent entry pathways, delineating guidelines on mAb usages in treating viral infections. Our study reveals a novel molecular mechanism for antibody-enhanced viral entry and can guide future vaccination and antiviral strategies. Significance Antibody-dependent enhancement (ADE) of viral entry has been observed for many viruses. It was shown that antibodies target one serotype of viruses but only sub-neutralize another, leading to ADE of the latter viruses. Here we identify a novel mechanism for ADE: a neutralizing antibody binds to the virus-surface spike protein of coronaviruses like a viral receptor, triggers a conformational change of the spike, and mediates viral entry into IgG-Fc-receptor-expressing cells through canonical viral-receptor-dependent pathways. We further evaluated how antibody dosages impacted viral entry into cells expressing viral receptor, Fc receptor, or both receptors. This study reveals complex roles of antibodies in viral entry and can guide future vaccine design and antibody-based drug therapy.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI089728)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI110700)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI139092)
This publication has 68 references indexed in Scilit:
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing AntibodiesJournal of Virology, 2013
- Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like ProteaseJournal of Virology, 2011
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR PathwayJournal of Virology, 2011
- Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infectionRetrovirology, 2011
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in HumansScience, 2010
- Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In VitroPLOS ONE, 2009
- Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cellsBiochemical and Biophysical Research Communications, 2009
- Coronaviruses post-SARS: update on replication and pathogenesisNature Reviews Microbiology, 2009
- Neutralizing Antibodies after Infection with Dengue 1 VirusEmerging Infectious Diseases, 2007
- Conformational States of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein EctodomainJournal of Virology, 2006